CVS Stock Trades Near 52-Week Low: Should You Buy the Dip?

CVS Health (CVS) shareholders are experiencing a rough period as the stock continues to face significant downward pressure. Recent reports about the company's strategic restructuring plans have placed the healthcare giant back in the headlines, raising concerns about its long-term stability and growth prospects. To address mounting financial pressure, CVS is reportedly considering a strategic restructuring that involves reducing costs by $2 billion, which could result in 2,900 job cuts.Accordingly, CVS Heal ...